CN113354579B - 一种4-氨基烟酸甲酯的高收率合成方法 - Google Patents
一种4-氨基烟酸甲酯的高收率合成方法 Download PDFInfo
- Publication number
- CN113354579B CN113354579B CN202110798884.XA CN202110798884A CN113354579B CN 113354579 B CN113354579 B CN 113354579B CN 202110798884 A CN202110798884 A CN 202110798884A CN 113354579 B CN113354579 B CN 113354579B
- Authority
- CN
- China
- Prior art keywords
- acid
- reaction
- pyridine
- synthesis method
- yield
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001308 synthesis method Methods 0.000 title claims abstract description 17
- OCARFFAPQGYGBP-UHFFFAOYSA-N methyl 4-aminopyridine-3-carboxylate Chemical compound COC(=O)C1=CN=CC=C1N OCARFFAPQGYGBP-UHFFFAOYSA-N 0.000 title claims description 38
- 238000006243 chemical reaction Methods 0.000 claims abstract description 46
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims abstract description 15
- MUYSADWCWFFZKR-UHFFFAOYSA-N cinchomeronic acid Chemical compound OC(=O)C1=CC=NC=C1C(O)=O MUYSADWCWFFZKR-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 230000018044 dehydration Effects 0.000 claims abstract description 5
- 238000006297 dehydration reaction Methods 0.000 claims abstract description 5
- 229910021529 ammonia Inorganic materials 0.000 claims abstract description 4
- 238000006467 substitution reaction Methods 0.000 claims abstract description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 38
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 32
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 24
- 238000010992 reflux Methods 0.000 claims description 20
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 18
- KFKMGUPDWTWQFM-UHFFFAOYSA-N furo[3,4-c]pyridine-1,3-dione Chemical compound N1=CC=C2C(=O)OC(=O)C2=C1 KFKMGUPDWTWQFM-UHFFFAOYSA-N 0.000 claims description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 13
- 238000012544 monitoring process Methods 0.000 claims description 12
- 239000012153 distilled water Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 9
- YNBADRVTZLEFNH-UHFFFAOYSA-N Methyl nicotinate Natural products COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 229960001238 methylnicotinate Drugs 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- PUXXPJODVNKSAT-UHFFFAOYSA-N 4-carbamoylpyridine-3-carboxylic acid Chemical compound NC(=O)C1=CC=NC=C1C(O)=O PUXXPJODVNKSAT-UHFFFAOYSA-N 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 238000001704 evaporation Methods 0.000 claims description 4
- 230000001376 precipitating effect Effects 0.000 claims description 4
- 239000007800 oxidant agent Substances 0.000 claims description 3
- 230000001590 oxidative effect Effects 0.000 claims description 3
- 230000003197 catalytic effect Effects 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 238000000967 suction filtration Methods 0.000 claims description 2
- 230000008707 rearrangement Effects 0.000 claims 1
- 238000007167 Hofmann rearrangement reaction Methods 0.000 abstract description 4
- 235000001968 nicotinic acid Nutrition 0.000 abstract 2
- 239000011664 nicotinic acid Substances 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 description 14
- 238000003786 synthesis reaction Methods 0.000 description 14
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- ITQTTZVARXURQS-UHFFFAOYSA-N 3-methylpyridine Chemical compound CC1=CC=CN=C1 ITQTTZVARXURQS-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000012286 potassium permanganate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- XYYYTUCWSSREHK-UHFFFAOYSA-N N1=CC=CC=C1.[N]=O Chemical compound N1=CC=CC=C1.[N]=O XYYYTUCWSSREHK-UHFFFAOYSA-N 0.000 description 1
- SARBWQDFRCAJGR-UHFFFAOYSA-N [N]=O.CC=1C=NC=CC1[N+](=O)[O-] Chemical compound [N]=O.CC=1C=NC=CC1[N+](=O)[O-] SARBWQDFRCAJGR-UHFFFAOYSA-N 0.000 description 1
- USBHQTSMWCBZJE-UHFFFAOYSA-N [O-][N+]([Fe])=O Chemical compound [O-][N+]([Fe])=O USBHQTSMWCBZJE-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 238000007867 post-reaction treatment Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/803—Processes of preparation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
Abstract
本发明公开了一种4‑氨基烟酸甲酯的高收率合成方法,以3,4‑吡啶二羧酸为原料,经过分子内脱水取代、氨气氨化、改良型NBS霍夫曼重排后水解得到所述4‑氨基烟酸甲酯。本发明合成方法,操作更加简单,反应条件温和,总收率也更高,具有极高的应用价值。
Description
技术领域
本发明属于化学制药领域,具体涉及一种4-氨基烟酸甲酯的高收率合成方法。
背景技术
4-氨基烟酸甲酯是一种常用的医药中间体,其传统的合成方法主要由以下两种方法:
以3-甲基吡啶为起始原料,先氧化生成吡啶氮氧化物,再经硝化、还原引入氨基,氨基保护后,高锰酸钾氧化甲基、氨基去保护,最后进行酯化反应,经七步反应完成4-氨基烟酸甲酯的合成,合成路线如下所示。该法的关键中间体3-甲基-4-硝基吡啶氮氧化物具有***性,操作不安全;甲基的高锰酸钾氧化、硝基的铁粉还原收率均不高、反应后处理繁琐;氨基的保护、去保护操作不可避免,导致合成路线长,不宜大规模制备。
以3,4-吡啶二羧酸为原料,先与乙酸酐作用下分子内脱水得3,4-吡啶二甲酸酐,在经氨水氨化、霍夫曼降解、酯化得到目标产物,合成路线如下所示。该方法操作复杂,生产能耗高,收率低,据文献介绍收率为70%左右。
发明内容
本发明针对现有技术存在的不足,提供了一种4-氨基烟酸甲酯的高收率合成方法。本发明以3,4-吡啶二羧酸为原料,先与乙酸酐作用下分子内脱水得3,4-吡啶二甲酸酐,然后第二步溶剂换为二氯甲烷,氨水换为氨气进行氨化,使得本步反应更加完全,3-羧酸-4-酰胺吡啶中间体的产率提高,接着进行改良型NBS霍夫曼重排反应,最后直接进行水解反应即可得到4-氨基烟酸甲酯。
本发明4-氨基烟酸甲酯的高收率合成方法,包括以下步骤:
步骤1:将3,4-吡啶二羧酸、乙酸酐加入反应瓶,控制温度115℃反应,TLC监测,约2-3h反应完毕后,减压浓缩,蒸去乙酸和乙酸酐,剩余油状物冷却至室温变为固体,得到3,4-吡啶二甲酸酐;
步骤2:将3,4-吡啶二甲酸酐溶于溶剂中,室温下(20℃-30℃)通入氨气进行反应,TLC监测,约2-3h反应完毕后,用盐酸调pH至4左右,有固体析出,过滤后再用蒸馏水洗涤,抽滤烘干得3-羧酸-4-酰胺吡啶;
步骤3:将3-羧酸-4-酰胺吡啶、碱和甲醇加入带有回流装置的圆底三口烧瓶中,升温至65℃,回流15min后,缓慢加入氧化剂,继续回流反应,通过TLC监测,约1.5h反应完毕后,直接进行下一步反应,加入一定催化量的酸和两个当量的蒸馏水(以3-羧酸-4-酰胺吡啶为基准),继续加热回流,点板观察,反应完毕后,乙酸乙酯萃取,减压弄缩,蒸去溶剂,烘干得4-氨基烟酸甲酯。
步骤2中,所述溶剂为二氯甲烷。
步骤2中,盐酸的浓度为20%。
步骤3中,所述氧化剂为NBS,所述碱为甲醇钠。
步骤3中,4-(氨基羰基)-3-吡啶羧酸和甲醇钠的摩尔比为1:2,4-(氨基羰基)-3-吡啶羧酸和NBS的摩尔比为1:1.1。
步骤3中,所述酸一般为强酸,如盐酸、硫酸等。
步骤3中,前一步反应完成后可以直接进行下一步水解反应,减少步骤操作,并提高产率。
本发明合成路线如下所示:
本发明合成方法以3,4-吡啶二羧酸为原料,经过分子内脱水取代、氨气氨化、改良型NBS霍夫曼重排后水解得到所述4-氨基烟酸甲酯,操作更加简单,反应条件温和,总收率高,具有极高的应用价值。
附图说明
图1为本发明所用原料3,4-吡啶二羧酸的核磁共振氢谱图。
图2为本发明所得产品4-氨基烟酸甲酯的核磁共振氢谱图。
具体实施方式
下面通过具体的实施例对本发明技术方案作进一步阐述,这些实施例只是为了说明问题,并不是一种限制。
实施例1:
本实施例中4-氨基烟酸甲酯的高收率合成方法包括以下步骤:
1、3,4-吡啶二甲酸酐的合成
将3,4-吡啶二羧酸(70g,0.42mol)和乙酸酐(180ml,1.91mol)加入反应瓶中,油浴加热至115℃,搅拌反应,TLC监测,约2-3h后反应完毕,减压浓缩,剩余的油状物降至室温变为固体,得到3,4-吡啶二甲酸酐55g,收率87.8%,HPLC纯度为98%。
2、3-羧酸-4-酰胺吡啶的合成
将上述3,4-吡啶二甲酸酐(50g,0.34mol)和200ml二氯甲烷加入反应瓶中,室温下(20℃-30℃)通入氨气进行反应,TLC监测,约2-3h后反应完毕,用盐酸调pH至4左右,有固体物析出,过滤,蒸馏水洗涤,干燥后得3-羧酸-4-酰胺吡啶51.3g,收率90.8%,HPLC纯度为98.4%。
3、4-氨基烟酸甲酯的合成
将3-羧酸-4-酰胺吡啶(20g,0.12mol)、甲醇钠(13g,0.24mol)和100ml甲醇加入带有回流装置的圆底三口烧瓶中,升温至65℃,回流15min后,缓慢加入NBS(23.5g,0.132mol),继续回流反应,TLC监测,约1.5h后反应完毕,加入15ml盐酸和5ml的蒸馏水,继续加热回流,点板观察,约0.5h反应完毕,用乙酸乙酯萃取三次,减压浓缩,蒸去溶剂,固体烘干得4-氨基烟酸甲酯16.1g,收率88.2%,HPLC纯度99.3%。
1H NMR(400MHz,DMSO-d6)δ8.66(s,1H),8.06(d,J=5.9Hz,1H),7.24(s,2H),6.68(d,J=6.2Hz,1H),3.81(s,3H).
实施例2:
本实施例中4-氨基烟酸甲酯的高收率合成方法包括以下步骤:
1、3,4-吡啶二甲酸酐的合成
将3,4-吡啶二羧酸(70g,0.42mol)和乙酸酐(180ml,1.91mol)加入反应瓶中,油浴加热至115℃,搅拌反应,TLC监测,约2-3h后反应完毕,减压浓缩,剩余的油状物降至室温变为固体,得到3,4-吡啶二甲酸酐56.1g,收率89.6%,HPLC纯度为96.8%。
2、3-羧酸-4-酰胺吡啶的合成
将上述3,4-吡啶二甲酸酐(50g,0.34mol)和200ml二氯甲烷加入反应瓶中,室温下(20℃-30℃)通入氨气进行反应,TLC监测,约2-3h后反应完毕,用盐酸调pH至4左右,有固体物析出,过滤,蒸馏水洗涤,干燥后得3-羧酸-4-酰胺吡啶50.2g,收率89%,HPLC纯度为98.6%。
3、4-氨基烟酸甲酯的合成
将3-羧酸-4-酰胺吡啶(20g,0.12mol)、甲醇钠(13g,0.24mol)和100ml甲醇加入带有回流装置的圆底三口烧瓶中,升温至65℃,回流15min后,缓慢加入NBS(23.5g,0.132mol),继续回流反应,TLC监测,约1.5h后反应完毕,加入15ml盐酸和5ml的蒸馏水,继续加热回流,点板观察,约0.5h反应完毕,用乙酸乙酯萃取三次,减压浓缩,蒸去溶剂,固体烘干得4-氨基烟酸甲酯16.4g,收率89.8%,HPLC纯度98.1%。
1H NMR(400MHz,DMSO-d6)δ8.66(s,1H),8.06(d,J=5.9Hz,1H),7.24(s,2H),6.68(d,J=6.2Hz,1H),3.81(s,3H).
实施例3:
本实施例中4-氨基烟酸甲酯的高收率合成方法包括以下步骤:
1、3,4-吡啶二甲酸酐的合成
将3,4-吡啶二羧酸(70g,0.42mol)和乙酸酐(180ml,1.91mol)加入反应瓶中,油浴加热至115℃,搅拌反应,TLC监测,约2-3h后反应完毕,减压浓缩,剩余的油状物降至室温变为固体,得到3,4-吡啶二甲酸酐55.4g,收率88.5%,HPLC纯度为97.5%。
2、3-羧酸-4-酰胺吡啶的合成
将上述3,4-吡啶二甲酸酐(50g,0.34mol)和200ml二氯甲烷加入反应瓶中,室温下(20℃-30℃)通入氨气进行反应,TLC监测,约2-3h后反应完毕,用盐酸调pH至4左右,有固体物析出,过滤,蒸馏水洗涤,干燥后得3-羧酸-4-酰胺吡啶49.7g,收率88.1%,HPLC纯度为99.1%。
3、4-氨基烟酸甲酯的合成
将3-羧酸-4-酰胺吡啶(20g,0.12mol)、甲醇钠(13g,0.24mol)和100ml甲醇加入带有回流装置的圆底三口烧瓶中,升温至65℃,回流15min后,缓慢加入NBS(23.5g,0.132mol),继续回流反应,TLC监测,约1.5h后反应完毕,加入15ml盐酸和5ml的蒸馏水,继续加热回流,点板观察,约0.5h反应完毕,用乙酸乙酯萃取三次,减压浓缩,蒸去溶剂,固体烘干得4-氨基烟酸甲酯16.2g,收率88.7%,HPLC纯度99%。
1H NMR(400MHz,DMSO-d6)δ8.66(s,1H),8.06(d,J=5.9Hz,1H),7.24(s,2H),6.68(d,J=6.2Hz,1H),3.81(s,3H).
通过以上三个实施例可得出以下结论:
1、在合成3,4-吡啶二甲酸酐时,应当加入过量的乙酸酐,使其能与3,4-吡啶二羧酸能够充分的反应,从而提高3,4-吡啶二甲酸酐的产率。
2、在合成3-羧酸-4-酰胺吡啶时,应当让氨气与反应液充分地接触,使3,4-吡啶二甲酸酐能够充分的反应,从而提高3-羧酸-4-酰胺吡啶的产率。
3、在合成4-氨基烟酸甲酯时,应当加入过量的NBS,使3-羧酸-4-酰胺吡啶能够充分的反应,从而提高最终产品4-氨基烟酸甲酯的产率。
本发明所提供的实验路径可行,所得最终产品4-氨基烟酸甲酯的产率和纯度也较之前方法有较大的提升。
本发明提供了一种4-氨基烟酸甲酯的高收率合成方法,以3,4-吡啶二羧酸为原料,经过分子内脱水取代、氨气氨化、改良型NBS霍夫曼重排后水解得到所述4-氨基烟酸甲酯,反应条件温和,总收率在85%以上,据文献所介绍的总收率70%有较大提高,并且操作也更加简化,具有极高的应用。
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离发明原理的前提下,还可以做出若干改进,这些改进也应视为本发明的保护范围。
Claims (4)
1.一种4-氨基烟酸甲酯的高收率合成方法,其特征在于:
以3,4-吡啶二羧酸为原料,经过分子内脱水取代、氨气氨化、改良型NBS霍夫曼重排后水解得到目标产物4-氨基烟酸甲酯;合成路线如下所示:
包括以下步骤:
步骤1:将3,4-吡啶二羧酸、乙酸酐加入反应瓶,控制温度115℃反应,TLC监测反应完毕,减压浓缩,蒸去乙酸和乙酸酐,剩余油状物冷却至室温变为固体,得到3,4-吡啶二甲酸酐;
步骤2:将3,4-吡啶二甲酸酐溶于溶剂二氯甲烷中,室温下通入氨气进行反应,TLC监测反应完毕,用盐酸调pH至4,有固体析出,过滤后再用蒸馏水洗涤,抽滤烘干得3-羧酸-4-酰胺吡啶;
步骤3:将3-羧酸-4-酰胺吡啶、甲醇钠和甲醇加入带有回流装置的圆底三口烧瓶中,升温至65℃,回流15min后,缓慢加入氧化剂NBS,继续回流反应,通过TLC监测反应完毕,直接进行下一步反应,加入一定催化量的酸和以3-羧酸-4-酰胺吡啶为基准当量下两个当量的蒸馏水,继续加热回流,反应完毕后乙酸乙酯萃取,减压浓缩,蒸去溶剂,烘干得4-氨基烟酸甲酯。
2.根据权利要求1所述的合成方法,其特征在于:
步骤2中,盐酸的浓度为20%。
3.根据权利要求1所述的合成方法,其特征在于:
步骤3中,4-(氨基羰基)-3-吡啶羧酸和甲醇钠的摩尔比为1:2,4-(氨基羰基)-3-吡啶羧酸和NBS的摩尔比为1:1.1。
4.根据权利要求1所述的合成方法,其特征在于:
步骤3中,所述酸为盐酸或硫酸。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110798884.XA CN113354579B (zh) | 2021-07-15 | 2021-07-15 | 一种4-氨基烟酸甲酯的高收率合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110798884.XA CN113354579B (zh) | 2021-07-15 | 2021-07-15 | 一种4-氨基烟酸甲酯的高收率合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113354579A CN113354579A (zh) | 2021-09-07 |
CN113354579B true CN113354579B (zh) | 2024-05-14 |
Family
ID=77539525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110798884.XA Active CN113354579B (zh) | 2021-07-15 | 2021-07-15 | 一种4-氨基烟酸甲酯的高收率合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113354579B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102161640A (zh) * | 2011-03-04 | 2011-08-24 | 南京理工大学 | 3,5-二氨基吡啶及3,5-二甲氧羰基氨基吡啶的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY192039A (en) * | 2017-04-27 | 2022-07-24 | Ishihara Sangyo Kaisha | N-(4-pyridyl)nicotinamide compound or salt thereof |
-
2021
- 2021-07-15 CN CN202110798884.XA patent/CN113354579B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102161640A (zh) * | 2011-03-04 | 2011-08-24 | 南京理工大学 | 3,5-二氨基吡啶及3,5-二甲氧羰基氨基吡啶的制备方法 |
Non-Patent Citations (4)
Title |
---|
4-氨基烟酸的合成研究;苏策等;《高校化学工程学报》;第24卷(第5期);第909页第2.3节 * |
Direct Probing of Regioregularity for Polycarbodiimide Systems via 15N NMR Analysis;James F. Reuther等;《Macromolecules》;第45卷;第7721页方案2、右栏最后一段、第7722页左栏第2段 * |
o-Aminoformylquinolines, new heterocyclic synthons;Godard, Alain等;《Journal of Heterocyclic Chemistry》;第17卷;第465-473页 * |
不同甲酯化方法分析羊肉膻味脂肪酸;李秋桐等;《中国调味品》;第44卷(第12期);第148-154页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113354579A (zh) | 2021-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108424388A (zh) | 一种慢性贫血药物的制备方法 | |
CN113387881B (zh) | 一种3-氨基异烟酸甲酯的合成方法 | |
CN114685468A (zh) | 用于治疗子宫肌瘤的药物的中间体化合物及其制备方法 | |
CN113354579B (zh) | 一种4-氨基烟酸甲酯的高收率合成方法 | |
CN118436116A (zh) | 一种尼古丁及其衍生物、制备方法 | |
CN113512000A (zh) | 一种规模化生产4’-溴-2,2’:6’,2”-三联吡啶的方法 | |
CN113979937B (zh) | 一种由芳香杂环化合物制备取代芳香杂环化合物的方法 | |
CN114262291B (zh) | 一种阿伐可泮的合成方法 | |
CN115417759A (zh) | 一种利用芥酸氧化还原活性酯制备神经酸的方法 | |
CN113501771A (zh) | 一种n-(2-氨乙基)甘氨酸衍生物的制备方法 | |
CN107216335A (zh) | 一种叔丁基1‑(羟甲基)‑3‑氧杂‑9‑氮杂螺[5.5]十一烷‑9‑甲酸基酯制法 | |
EP3026047A1 (en) | Method for producing heterocyclic compound | |
CN111269149A (zh) | 一种5-(3,3-二甲基胍基)-2-氧代戊酸的生产工艺 | |
CN115626893B (zh) | 一种2-羟基-5-羟甲基吡啶的合成方法 | |
CN114644636B (zh) | 一种制备托法替尼关键中间体的方法 | |
CN115322118B (zh) | 一种盐酸贝尼地平中间体的制备方法 | |
CN117777015A (zh) | 一种3-氨基-2-吡啶甲酸的合成方法 | |
CN113087654B (zh) | 哌啶-4-丁胺的制备方法 | |
CN113354558B (zh) | 一种2-氨基-5-氟苯腈的制备方法 | |
CN112898130B (zh) | 一种高选择性合成9-芴甲醇的方法 | |
CN112300059B (zh) | 一种pf-06651600中间体的制备方法 | |
CN114685410B (zh) | 一种丁苯酞的制备方法 | |
CN111004141B (zh) | 一种尼达尼布中间体2-氯-n-甲基-n-(4-硝基苯基)乙酰胺合成新方法 | |
CN117534613A (zh) | 一种3-氨基吡啶-2-羧酸甲酯的制备方法 | |
CN118420578A (zh) | 一种1-氯二苯并呋喃的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |